366 related articles for article (PubMed ID: 12452733)
1. Comparative tolerability of contrast media used for coronary interventions.
Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
[TBL] [Abstract][Full Text] [Related]
2. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model.
Duan SB; Wang YH; Liu FY; Xu XQ; Wang P; Zou Q; Peng YM
Acta Radiol; 2009 Sep; 50(7):754-9. PubMed ID: 19452295
[TBL] [Abstract][Full Text] [Related]
3. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
[TBL] [Abstract][Full Text] [Related]
4. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
5. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials.
Pandya B; Chalhoub JM; Parikh V; Gaddam S; Spagnola J; El-Sayegh S; Bogin M; Kandov R; Lafferty J; Bangalore S
Int J Cardiol; 2017 Feb; 228():137-144. PubMed ID: 27863354
[TBL] [Abstract][Full Text] [Related]
6. Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid Conditions.
McCullough P; Ng CS; Ryan M; Baker ER; Mehta R
Cardiorenal Med; 2021; 11(4):193-199. PubMed ID: 34433166
[TBL] [Abstract][Full Text] [Related]
7. Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention.
McCullough PA; David G; Todoran TM; Brilakis ES; Ryan MP; Gunnarsson C
J Comp Eff Res; 2018 Apr; 7(4):331-341. PubMed ID: 29117715
[TBL] [Abstract][Full Text] [Related]
8. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro.
Duan S; Zhou X; Liu F; Peng Y; Chen Y; Pei Y; Ling G; Zhou L; Li Y; Pi Y; Tang K; Liu R; Li G
J Nephrol; 2006; 19(6):717-24. PubMed ID: 17173243
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
Wang YC; Tang A; Chang D; Lu CQ; Zhang SJ; Ju S
Am J Cardiol; 2016 Oct; 118(7):985-90. PubMed ID: 27521223
[TBL] [Abstract][Full Text] [Related]
10. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
11. Contrast agents and renal cell apoptosis.
Romano G; Briguori C; Quintavalle C; Zanca C; Rivera NV; Colombo A; Condorelli G
Eur Heart J; 2008 Oct; 29(20):2569-76. PubMed ID: 18468994
[TBL] [Abstract][Full Text] [Related]
12. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
13. Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.
Premawardhana D; Sekar B; Ul-Haq MZ; Sheikh A; Gallagher S; Anderson R; Copt S; Ossei-Gerning N; Kinnaird T
Minerva Cardioangiol; 2019 Oct; 67(5):380-391. PubMed ID: 31527583
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
[TBL] [Abstract][Full Text] [Related]
15. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
Morcos SK
Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
[TBL] [Abstract][Full Text] [Related]
16. Iso-osmolar vs low-osmolar contrast agents for coronary optical coherence tomography: a blinded prospective randomized controlled study.
Kostantinis S; Mastrodemos O; Stanberry L; Sandoval Y; Allana SS; Mutlu D; Simsek B; Rempakos A; Karacsonyi J; Alexandrou M; Okeson BK; Burke MN; Rangan BV; Brilakis ES
J Invasive Cardiol; 2024 Jun; 36(6):. PubMed ID: 38446023
[TBL] [Abstract][Full Text] [Related]
17. Different outcomes between iso-osmolar and low-osmolar contrast media in acute myocardial infarction with renal impairment.
Oh S; Kim JS; Ahn Y; Ahn JH; Hyun DY; Lee SH; Cho KH; Kim MC; Sim DS; Hong YJ; Kim JH; Jeong MH
Cardiol J; 2023; 30(5):790-798. PubMed ID: 34931692
[TBL] [Abstract][Full Text] [Related]
18. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
Lasser EC; Lyon SG; Berry CC
Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
[TBL] [Abstract][Full Text] [Related]
19. Heart rate variability and heat sensation during CT coronary angiography: Low-osmolar versus iso-osmolar contrast media.
Svensson A; Ripsweden J; Rück A; Aspelin P; Cederlund K; Brismar BT
Acta Radiol; 2010 Sep; 51(7):722-6. PubMed ID: 20568977
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media.
Spinler SA; Goldfarb S
Ann Pharmacother; 1992 Jan; 26(1):56-64. PubMed ID: 1606346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]